Metraipolis › archive › dc_6fd4052085b2

Postmarketing Safety Concerns With FDA Black Box Warning Monoclonal Antibodies: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System… — Europe PMC PMID:42113643

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42113643
DOI
10.1097/pts.0000000000001513
License (as archived)
solo-consultazione
Archived
2026-11-02T12:45:27.172Z
SHA-256 of the archived text
3952bc5320ae8c727b360c0a0e71da0f537efde593f71536a54ac98385b31804
Stable URL of this page
https://metraipolis.com/documento/dc_6fd4052085b2

How to cite

Postmarketing Safety Concerns With FDA Black Box Warning Monoclonal Antibodies: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System… — Europe PMC PMID:42113643 — Europe PMC (en), https://europepmc.org/article/MED/42113643 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6fd4052085b2 (Metraipolis archive dc_6fd4052085b2, sha256 3952bc5320ae8c727b360c0a0e71da0f537efde593f71536a54ac98385b31804)
BibTeX
@misc{dc6fd4052085b2,
  title = {Postmarketing Safety Concerns With FDA Black Box Warning Monoclonal Antibodies: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System… — Europe PMC PMID:42113643},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42113643},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6fd4052085b2; sha256 3952bc5320ae8c727b360c0a0e71da0f537efde593f71536a54ac98385b31804},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42113643. Agents can read the archived copy with the MCP tool read_document.